First-Line Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia Is Associated With Overall Survival Rates Similar to Those of an Age-Matched General Population: A Pooled Post Hoc Analysis

Authors

Paolo Ghia
Carolyn Owen
John N Allan
Jacqueline C Barrientos
Paul M Barr
Chunxue Shi
Anita Szoke
Christopher Abbazio
Gabriel S Krigsfeld
Jan A Burger

Publication Date

5-1-2024

Journal

Hemasphere

DOI

10.1002/hem3.74

PMID

38803455

PMCID

PMC11129546

PubMedCentral® Posted Date

5-27-2024

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Recommended Citation

Ghia, Paolo; Owen, Carolyn; Allan, John N; et al., "First-Line Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia Is Associated With Overall Survival Rates Similar to Those of an Age-Matched General Population: A Pooled Post Hoc Analysis" (2024). Faculty, Staff and Student Publications. 4269.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4269